Investigational Drug Details

Drug ID: D538
Drug Name: Mazindol
Synonyms: Sanorex
Type: Chemical drug
DrugBank ID: DB00579
DrugBank Description: Mazindol is a sympathomimetic used to treat obesity in combination with lifestyle modifications.
PubChem ID: --
CasNo: 22232-71-9
Repositioning for NAFLD: Yes
SMILES: OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
Structure:
InChiKey: ZPXSCAKFGYXMGA-UHFFFAOYSA-N
Molecular Weight: 284.74
DrugBank Targets: Sodium-dependent noradrenaline transporter inhibitor; Sodium-dependent dopamine transporter inhibitor; Sodium-dependent serotonin transporter inhibitor; Synaptic vesicular amine transporter
DrugBank MoA: Unlike other sympathomimetic appetite suppressants such as phentermine, mazindol is thought to inhibit the reuptake of norepinephrine rather than to cause its release.
DrugBank Pharmacology: Mazindol is a sympathomimetic amine that stimulates the central nervous system (nerves and brain), leading to increased your heart rate and blood pressure, and decreased appetite. Since the appetite-suppressing effect of the drug tends to decrease after few weeks of treatment, sympathomimetic appetite suppressants are typically used short-term weight-loss program.
DrugBank Indication: Used in short-term (a few weeks) treatment of exogenous obesity in conjunction with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in patients with a body mass index of 30 kg of body weight per height in meters squared (kg/m2) or in patients with a body mass index of 27 kg/m2 in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.
Targets: --
Therapeutic Category: --
Clinical Trial Progress: Clinical trial on-going (JPRN-UMIN000022879)
Latest Progress: Under clinical trials